Jeff Yass Susquehanna International Group
Jeff Yass is a co-founder of Susquehanna International Group (SIG), a major global trading and market-making firm. SIG is known for options expertise, quantitative trading, and a training culture grounded in probabilistic decision-making. Yass’s firm is influential across derivatives markets even though it is less of a traditional long-only stock-picking franchise.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$4.05B |
| 2 |
iShares 20+ Year Treasury Bond ETF
TLT
|
+$1.61B |
| 3 |
Tesla
TSLA
|
+$636M |
| 4 |
TSMC
TSM
|
+$604M |
| 5 |
iShares Bitcoin Trust
IBIT
|
+$330M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Invesco QQQ Trust
QQQ
|
+$1.25B |
| 2 |
Apple
AAPL
|
+$1.13B |
| 3 |
Microsoft
MSFT
|
+$988M |
| 4 |
Meta Platforms (Facebook)
META
|
+$572M |
| 5 |
Berkshire Hathaway Class B
BRK.B
|
+$570M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 1.55% |
| 2 | Consumer Discretionary | 0.95% |
| 3 | Financials | 0.77% |
| 4 | Healthcare | 0.67% |
| 5 | Industrials | 0.49% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
11801
Entera Bio
ENTX
$552M
| $59.1K | ﹤0.01% |
34,766
-3,633
| -9% | -$7.9K |
|
11802
Martin Midstream Partners
MMLP
$86.9M
| $59.1K | ﹤0.01% |
16,416
-119,302
| -88% | -$428K |
|
11803
CALL
Lightwave Logic
LWLG
$899M
| $58.9K | ﹤0.01% |
57,200
-342,500
| -86% | -$534K |
|
11804
Yatra Online
YTRA
$64.6M
| $58.5K | ﹤0.01% |
74,583
-35,663
| -32% | -$37K |
|
|
AFCG
11805
PUT
AFC Gamma
AFCG
$78.2M
| $58.5K | ﹤0.01% |
10,500
-4,400
| -30% | -$35K |
|
11806
CALL
Nerdy
NRDY
$88.3M
| $58.2K | ﹤0.01% |
2,733
-674
| -20% | -$17K |
|
11807
Gerdau
GGB
$8.75B
| $58.2K | ﹤0.01% |
20,489
-66,609
| -76% | -$194K |
|
|
SANG
11808
Sangoma Technologies
SANG
$129M
| $57.9K | ﹤0.01% |
+12,625
| New | +$76.5K |
|
11809
Nautilus Biotechnolgy
NAUT
$119M
| $57.9K | ﹤0.01% |
67,293
+28,289
| +73% | +$42K |
|
11810
CALL
QuickLogic
QUIK
$204M
| $57.7K | ﹤0.01% |
11,300
-41,000
| -78% | -$308K |
|
|
KZR
11811
CALL
DELISTED
Kezar Life Sciences
KZR
| $57.6K | ﹤0.01% |
11,800
-400
| -3% | -$2.43K |
|
11812
Orion Energy Systems
OESX
$102M
| $56.9K | ﹤0.01% |
7,890
-5,071
| -39% | -$41K |
|
11813
PUT
Blend Labs
BLND
$355M
| $56.6K | ﹤0.01% |
+16,900
| New | +$61.4K |
|
11814
CALL
Personalis
PSNL
$1.82B
| $56.5K | ﹤0.01% |
+16,100
| New | +$76.5K |
|
|
11815
CALL
Gerdau
GGB
$8.75B
| $56.2K | ﹤0.01% |
19,800
-56,700
| -74% | -$166K |
|
11816
CALL
SES AI
SES
$199M
| $56.1K | ﹤0.01% |
107,900
-362,300
| -77% | -$333K |
|
|
NRO
11817
Neuberger Real Estate Securities Income Fund Inc
NRO
$188M
| $56.1K | ﹤0.01% |
16,995
-3,127
| -16% | -$10.5K |
|
|
BZUN
11818
CALL
Baozun
BZUN
$164M
| $56K | ﹤0.01% |
+20,500
| New | +$65.1K |
|
11819
Noodles & Co
NDLS
$86.7M
| $55.9K | ﹤0.01% |
+6,406
| New | +$63.1K |
|
11820
ETRACS 2x Monthly Pay Leveraged US Small Cap High Dividend ETN Series B
SMHB
$24.5M
| $55.5K | ﹤0.01% |
11,725
-25,966
| -69% | -$135K |
|
11821
Rockwell Medical
RMTI
$31.9M
| $55.4K | ﹤0.01% |
4,903
-9,540
| -66% | -$173K |
|
|
PPSI
11822
CALL
Pioneer Power Solutions
PPSI
$32.7M
| $55.3K | ﹤0.01% |
18,500
-31,400
| -63% | -$114K |
|
11823
CALL
Fossil Group
FOSL
$321M
| $55.2K | ﹤0.01% |
48,000
-118,100
| -71% | -$185K |
|
11824
CALL
Seres Therapeutics
MCRB
$47.8M
| $55.2K | ﹤0.01% |
3,940
-129,750
| -97% | -$2.03M |
|
11825
CALL
BARK
BARK
$95.2M
| $54.9K | ﹤0.01% |
1,975
+445
| +29% | +$15.6K |
|
Similar funds
Jeff Yass's Q1 2025 Portfolio in Review
As of Q1 2025, Jeff Yass held 13,842 positions worth $586B, down 12% from $663B the previous quarter. Its ten largest holdings account for 28% of the portfolio.
Jeff Yass withdrew a net $24.4B in Q1 2025, closing 1,482 positions and reducing 4,842 holdings. Its most notable exit was Inari Medical, Inc. Common Stock, an estimated $24M position sold in full.
By sector, the portfolio is most concentrated in Technology at 1.6% of assets, down from 2% a quarter earlier, followed by Consumer Discretionary and Financials.
Against the trend, Jeff Yass opened a new position in Brookfield Asset Management worth $86M.
- Jeff Yass's largest Q1 2025 buy was Brookfield Asset Management: 1,775,684 shares worth $86M.
- Jeff Yass added most to State Street SPDR S&P 500 ETF Trust in Q1 2025, an estimated $4.05B increase.
- Jeff Yass's biggest Q1 2025 reduction was Invesco QQQ Trust, cutting an estimated $1.25B.
- Jeff Yass fully exited Inari Medical, Inc. Common Stock in Q1 2025, selling an estimated $24M.
- Jeff Yass's ten largest holdings make up 28% of its $586B portfolio in Q1 2025.
- Jeff Yass opened 1,775 new positions and closed 1,482 in Q1 2025.
- Jeff Yass's portfolio value fell 12% quarter-over-quarter to $586B.
Based on Susquehanna International Group's 13F filing for Q1 2025, filed 14 May 2025.